1221191

L. Perrigo Company — FEI 1811666

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Allegan, MI (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)